Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies

New Developments in Fetal and Neonatal Alloimmune Thrombocytopenia

(2021) James B. Bussel et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events

(2020) Sandra Wienzek-Lischka et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk

(2020) Dian Winkelhorst et al.   BMJ Open

Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach

(2019) Lani Lieberman et al.   BRITISH JOURNAL OF HAEMATOLOGY

Fetal and neonatal alloimmune thrombocytopenia – The Norwegian management model

(2019) Heidi Tiller et al.   TRANSFUSION AND APHERESIS SCIENCE

Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review

(2018) Mette Kjaer et al.   VOX SANGUINIS

Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune ThrombocytopeniaHighlights

(2016) Sentot Santoso et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial

(2015) Noortje P. Paridaans et al.   FETAL DIAGNOSIS AND THERAPY

Incidence and Consequences of Neonatal Alloimmune Thrombocytopenia: A Systematic Review

(2014) M. M. Kamphuis et al.   PEDIATRICS

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

(2013) R. Kapur et al.   BLOOD

Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry

(2013) Heidi Tiller et al.   BMJ Open

Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia

(2011) G. Bertrand et al.   BLOOD

Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus

(2010) James B. Bussel et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?

(2010) Agnes Mechoulan et al.   Journal of Maternal-Fetal & Neonatal Medicine

Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts

(2010) G. Giers et al.   VOX SANGUINIS

Is it time to implement HPA-1 screening in pregnancy?

(2009) Anne Husebekk et al.   CURRENT OPINION IN HEMATOLOGY

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

(2008) M. K. Killie et al.   HAEMATOLOGICA